HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

/PRNewswire/ — HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune…Read More

What's Trending

InnoCORE 2026 Global Postdoctoral Job Fair Heads to Europe

There Is a Solution to the Global Health Care Crisis

20 years

Uganda’s President Signs Contentious Law Meant to Curb Foreign Influence

Uganda’s president signs contentious law meant to curb foreign influence

How will China’s bank restructuring law reshape the industry?

Are safe haven laws doing enough to protect infants in Ohio?

Uganda’s President Signs Contentious Law Meant to Curb Foreign Influence

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

InnoCORE 2026 Global Postdoctoral Job Fair Heads to Europe

There Is a Solution to the Global Health Care Crisis

20 years

Markel International appoints Sebastian Rice as Head of Global Development, Trade Credit

Leave A Reply Cancel Reply

What's Trending

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN